Literature DB >> 33786225

An Evaluation of the Use of Aggressive Fluid Resuscitation in the Early Treatment of Sepsis Patients.

William N Payne1, Alfred Tager1, Mike Broce2, Dany Tager3, Marion Hoy2, Hythem Abad1.   

Abstract

Introduction Fluid resuscitation is a critical aspect of the sepsis protocol with the usual initial dose being 30 mL per kilogram. Although this dose is well accepted in patients with normal cardiac function, there is some significant variation in clinical practice concerning the optimal fluid resuscitation in septic patients with underlying congestive heart failure (CHF). Many different approaches have been tried to best treat these patients by using lesser volumes of fluid. The purpose of this retrospective study is to attempt to better define optimal fluid resuscitation in congestive heart failure patients and whether standard fluid resuscitation exacerbates CHF in these cases. Methods This was a retrospective study involving patients admitted to the Emergency Department (ED) during the time period of September of 2016 through March of 2019 with a primary diagnosis of sepsis and pre-existing CHF. Data collected from the data warehouse and patient charts included demographics, total amount of fluid received in the ED and outcome data. Evidence of fluid overload (chest X-ray [CXR] evidence, rising B-type natriuretic peptide [BNP], or use of diuretics), was evaluated with respect to in-hospital mortality, white blood cell (WBC) count and comorbidities (chronic obstructive pulmonary disease [COPD], hypertension and coronary artery disease). Results There were 422 patients included in the cohort. Of the 422, 113 (26.8%) patients showed evidence of fluid overload on CXR during hospital stay and received diuretics and therefore considered in the CHF exacerbation group. The patients that experienced CHF exacerbation were significantly older (mean ± SD, 70.9 ± 11.8 years versus 67.4 ± 15.1 years, p=0.014). Patients with exacerbation also received more fluid (median and interquartile range, 3.0, 2:5.5 L versus 2.0, 1:4.3 L, p=0.017). The receiver operating characteristic curve analysis for fluid to predict exacerbation resulted in an area under the curve of 0.59 with a 95% confidence interval (CI) of 0.52 to 0.65, p=0.012. The Youden Index was used to determine an optimal cutoff value of 2.6 L. The percentage of patients in the exacerbation group above the threshold was significantly higher (57.3%) than those without exacerbation (43.3%), p=0.019. Following multivariate analysis, age greater than 60 (odds ratio [OR]: 2.5; CI: 1.4-4.6, p=0.003) and fluid cutoff of 2.6 L (OR: 1.9; CI: 1.2-3.1, p=0.007) were both found to be independent predictors of CHF exacerbation. There was no significant difference in mortality based on the total fluid received in the ED. Conclusion The findings of this study showed that septic patients with pre-existing CHF who received more than 2.6 L of fluid in the ED were 90% more likely to develop symptoms of CHF exacerbation with no evidence of lowering mortality compared to the group that received less than 2.6 L. Our data supports the practice of limiting total fluid resuscitation in CHF to 2.6 L and reconfirms the idea that fluid resuscitation for patients with CHF needs to be individualized.
Copyright © 2021, Payne et al.

Entities:  

Keywords:  chf exacerbation; congestive heart failure; fluid resuscitation; sepsis; sepsis treatment

Year:  2021        PMID: 33786225      PMCID: PMC7994009          DOI: 10.7759/cureus.13518

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  8 in total

1.  Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples.

Authors:  Enrique F Schisterman; Neil J Perkins; Aiyi Liu; Howard Bondell
Journal:  Epidemiology       Date:  2005-01       Impact factor: 4.822

2.  Toward a More Nuanced Approach to the Early Administration of Intravenous Fluids in Patients With Sepsis.

Authors:  Chanu Rhee; Andre C Kalil
Journal:  JAMA Netw Open       Date:  2018-12-07

3.  Adherence to fluid resuscitation guidelines and outcomes in patients with septic shock: Reassessing the "one-size-fits-all" approach.

Authors:  Tuyet-Trinh N Truong; Andrew S Dunn; Ken McCardle; Allison Glasser; Shirish Huprikar; Hooman Poor; Beth Raucher; Jashvant Poeran
Journal:  J Crit Care       Date:  2019-02-05       Impact factor: 3.425

4.  Equipoise in Appropriate Initial Volume Resuscitation for Patients in Septic Shock With Heart Failure: Results of a Multicenter Clinician Survey.

Authors:  Gabriel Wardi; Ian Joel; Julian Villar; Michael Lava; Eric Gross; Vaishal Tolia; Raghu R Seethala; Robert L Owens; Rebecca E Sell; Sydney B Montesi; Farbod N Rahaghi; Somnath Bose; Ashish Rai; Elizabeth K Stevenson; Jakob McSparron; Vaishal Tolia; Jeremy R Beitler
Journal:  J Intensive Care Med       Date:  2019-08-25       Impact factor: 2.889

5.  Outcomes of patients with systolic heart failure presenting with sepsis to the emergency department of a tertiary hospital: a retrospective chart review study from Lebanon.

Authors:  Gilbert Abou Dagher; Karim Hajjar; Christopher Khoury; Nadine El Hajj; Mohammad Kanso; Maha Makki; Aurelie Mailhac; Ralphe Bou Chebl
Journal:  BMJ Open       Date:  2018-08-01       Impact factor: 2.692

6.  A past medical history of heart failure is associated with less fluid therapy in septic patients.

Authors:  Carlos Rodrigo Franco Palacios; Amanda M Thompson; Federico Gorostiaga
Journal:  Rev Bras Ter Intensiva       Date:  2019-10-14

7.  Retrospective cause analysis of troponin I elevation in non-CAD patients: Special emphasis on sepsis.

Authors:  Chien-Wen Yang; Huijun Li; Lisa Thomas; Manuel Ramos; Po-Hong Liu; Thomas Roe; Ravinder Valadri; Michael C Kiel; Vincent Yi-Fong Su; Qi Shi
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

8.  Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.

Authors:  Giuseppe Vergaro; Nicolò Ghionzoli; Lisa Innocenti; Claudia Taddei; Alberto Giannoni; Alessandro Valleggi; Chiara Borrelli; Michele Senni; Claudio Passino; Michele Emdin
Journal:  J Am Heart Assoc       Date:  2019-10-05       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.